• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    43.94 0.98(2.18%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:44.92
    Open:44.49
    Bid:42.89 x 100
    Ask:51.00 x 1000
    1y Target Est:48.50
    Beta:0.543
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:42.91 - 44.69
    52wk Range:30.43 - 52.58
    Volume:711,574
    Avg Vol (3m):375,848
    Market Cap:817.46M
    P/E (ttm):24.41
    EPS (ttm):1.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ENTA

    Key Statistics

    Forward P/E (1 yr):10.69
    P/S (ttm):17.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :9.87
    Quarterly EPS Est (Dec-14) :3.82
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the infectious disease field in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback